- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02674815
Preoperative High Intensity Interval Training: The PHIIT Trial (PHIIT)
Preoperative High Intensity Interval Training in Patients Scheduled for Colorectal and Thoracic Surgery: The PHIIT Trial
Colorectal and thoracic surgical patients are susceptible to poor postoperative outcome including complications, mortality and increased length of stay. Preoperative physical fitness is protective against poor postoperative outcome in intra-abdominal and thoracic surgery.
The current colorectal/thoracic pathway from diagnosis to surgery is about 2 weeks and therefore interventions of longer duration are not feasible. Clinicians may be presented with a difficult choice in delaying surgery to perform prehab or cancel the pre-op intervention.
To create greater improvements in aerobic fitness, participants are required to exercise at high levels of VO2peak (e.g. ≥80% VO2peak). High intensity interval training (HIIT) requires participants to exercise at high levels of VO2peak (≥80% VO2peak) for short periods (e.g. 15 seconds) followed by a recovery (active or passive) and typically continue this pattern for 30 minutes or until exhaustion.
HIIT programmes are safe and a recent meta-analysis noted that HIIT produced a more pronounced incremental gain in participants' mean VO2peak when compared with continuous moderate intensity exercise (+1.78mL/kg/min, 95% CI: 0.45-3.11).
HITT has not been investigated as a preoperative intervention to either optimize fitness prior to surgery or reduce post-surgical complications. Preoperative HIIT is an intense intervention which will require significant participant adherence. The safety, cost and clinical application of such a programme needs to be performed. This feasibility study aims to assess the ability of HIIT to improve aerobic fitness two weeks prior to surgery and determine its feasibility.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Colorectal and thoracic surgical patients are susceptible to poor postoperative outcome. In colorectal surgery the rate of post-op complications is between 15-20% and the rate of 30 day mortality is 2.3%. Thoracic surgery also carries significant risk, 30 day mortality is 2.2% while the rate of post-op complications is 29.3%. Poor postoperative outcome significantly affects the patients recovery and increases hospital costs. Reducing postoperative risk therefore conveys significant benefit to the patient and the hospital.
Preoperative physical fitness is predictive of postoperative outcome in intra-abdominal and thoracic surgery. In a systematic review of 6 studies preoperative exercise interventions improved pre-op physical fitness in patients undergoing abdominal surgery, however it is unclear if this translates into an improvement in postoperative outcome.
An updated systematic review and meta-analysis was performed on the effects of pre-habilitation on postoperative outcome. While the results demonstrated that preoperative exercise interventions of 4-6 week duration reduced post-op complications a significant amount of work is still to be performed in this area.
The current colorectal/thoracic pathway from diagnosis to surgery is about 2 weeks and therefore interventions of longer duration are not feasible. Clinicians may be presented with a difficult choice in delaying surgery to perform prehab or cancel the pre-op intervention.
To create greater improvements in aerobic fitness, participants are required to exercise at high levels of VO2peak (e.g. ≥80% VO2peak). High intensity interval training (HIIT) requires participants to exercise at high levels of VO2peak (≥80% VO2peak). Participants exercise for short periods (15 seconds) followed by 15 seconds of rest and typically continue this pattern for 30 minutes or until exhaustion.
A recent review reported HIIT programmes to be safe in individuals with coronary artery disease and stable heart failure. In agreement with this paper a recent meta-analysis noted that HIIT produced a more pronounced incremental gain in participants' mean VO2peak when compared with continuous moderate intensity exercise There are a number of factors to take into account when designing a HIIT programme e.g. duration and intensity of exercise phase and type of recovery period (active vs. passive). Two papers compared a selection of HIIT protocols for safety and time at a high percentage of VO2peak (≥ 80% VO2peak). Protocols with rest periods (passive recovery) allowed patients to exercise for longer and had lower perceived difficulties. In one study of 20 patients with CAD, HITT was prescribed with 15s exercise and passive recovery intervals at 100% Peak Power Output (PPO) or Maximal Aerobic Power (MAP) with no adverse events. PPO or MAP is the power of the last completed stage during a maximal exercise test (watts). This intervention had the highest duration above 80% VO2peak (819s) and a high completion rate of 63%. This protocol was chosen for this study.
HITT has not been investigated as a preoperative intervention to either optimize fitness prior to surgery or reduce postsurgical complications. Preoperative HIIT is an intense intervention which will require significant participant adherence. The safety, cost and clinical application of such a programme needs to be performed. This feasibility study aims to assess the ability of HIIT to improve aerobic fitness two weeks prior to surgery and determine its feasibility.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dublin, Ireland
- St. James's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients scheduled for colorectal or thoracic surgery
- Able to give informed consent
- Ability to understand English
Exclusion Criteria:
- Acute myocardial infarction
- Unstable angina
- Uncontrolled arrhythmias causing symptoms or hemodynamic compromise
- Syncope
- Active endocarditis
- Symptomatic severe aortic stenosis
- Uncontrolled heart failure
- Acute pulmonary embolous or pulmonary infarction
- Thrombosis of lower extremities
- Suspected dissecting aneurysm
- Uncontrolled asthma
- Pulmonary edema
- Room air desaturation at rest ≤85%
- Respiratory failure
- Acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise (i.e. infection, renal failure, thyrotoxicosis)
- Cognitive impairment leading to inability to cooperate
- Left main coronary stenosis or equivalent
- Moderate stenotic valvular heart disease
- Severe untreated arterial hypertension at rest (>200 mmHg systolic, >120 mmHg diastolic)
- Tachyarrhythmias or bradyarrhythmias
- High-degree atrioventricular block
- Hypertrophic cardiomyopathy
- Significant pulmonary hypertension
- Pregnancy
- Electrolyte abnormalities
- Orthopaedic impairment that compromises exercise performance
- Individuals with pacemakers or defibrillators
- Epilepsy
- Past history or MRI evidence of brain damage, including significant trauma, stroke, transient ischaemic attack (TIA), hydrocephalus, mental retardation, or serious neurological disorder
- Non resectable disease
- Emergency surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Patients within this arm will perform two weeks of high intensity interval training prior to colorectal/thoracic surgery.
Exercise intensity will be 100% of the peak power output (PPO) during maximal cardiopulmonary exercise testing.
Patients will exercise for 15 seconds at 100% PPO and rest for 15 seconds (passive) for 30 minutes or until exhaustion.
This will be performed 5 days a week for 2 weeks.
|
High intensity interval training (HIIT) requires participants to exercise at high levels of VO2peak (≥80% VO2peak).
Participants exercise for short periods (e.g.
15-30 seconds) followed by periods of rest (active or passive) and typically continue this pattern for a set time period or until exhaustion.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost
Time Frame: 6 months
|
The cost of the programme will be recorded.
Expected costs include, parking, room rental charges, equipment rates, employee rates.
|
6 months
|
Adherence/Compliance
Time Frame: 6 months
|
The adherence rates will be measured by recording the number of appointments each participant attends. The number of missed sessions per participant and the reasons for missing sessions will be recorded and reported. If a participant misses an exercise sessions they will be contacted by the research team to determine the reason and to reschedule the class for later that day if possible. If a participant misses more than 50% of total exercise sessions in the absence of a defined reason (acute illness or scheduled holiday), it will be recorded as a protocol violation. |
6 months
|
Incidence of Adverse Events
Time Frame: 6 months
|
Adverse events will be assessed at every clinic visit and the following details recorded: type, incidence, severity, timing, seriousness, and relatedness to a) disease and b) the intervention.
|
6 months
|
Satisfaction/Acceptability
Time Frame: 6 months
|
Self-administered questionnaire on completion of programme will be administered.
Participants will also be asked to highlight what they liked and didn't like about the programme and any suggestions for change.
|
6 months
|
Withdrawal of participants
Time Frame: 6 months
|
Participants are free to withdraw from the trial at any stage without providing a reason and without consequence.
This information will be stated in the participant information leaflet.
Participants can inform the research team at their local site of their decision to withdraw.
If a participant withdraws from the study, any data collected on them up to that point in the study will go forward for study analysis.
This information will be stated in the participant information leaflet.
If a participant withdraws from the intervention, but provides consent to complete subsequent follow-up measurements they will continue to attend study assessments and data will be used for intention-to-treat analysis.
Participants will be asked for their reason to withdrawing consent, participants are not required to give a reason.
Reasons for stopping the intervention will be recorded and reported
|
6 months
|
Protocol deviations/Adaptations
Time Frame: 6 months
|
The following deviations will be recorded and reported. • Changes to exercise protocol (e.g. reduction in number of sessions, change in % PPO performed during exercise session) |
6 months
|
Compliance
Time Frame: 6 months
|
Compliance will be measured in the percentage of exercise sessions attended and successfully completed.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative mortality
Time Frame: Up to day 30 post-op
|
Postoperative mortality will be recorded until day 30 post-op.
|
Up to day 30 post-op
|
Changes in Aerobic Capacity
Time Frame: 6 months
|
Participants will perform a maximal CPET prior to beginning of intervention to establish baseline aerobic fitness.
Upon completion of the intervention, prior to surgery, participants will repeat the maximal CPET.
|
6 months
|
Length of stay
Time Frame: 6 months
|
Length of stay will include general hospital stay from time of operation to discharge, ICU/HDU admission rates and length of stay as well as readmission rates.
|
6 months
|
Postoperative complications assessed using the Postoperative Morbidity Survey
Time Frame: Up to 7 days post-op
|
Postoperative morbidity will be assessed using the postoperative morbidity survey (POMS) (type and number of complications on a specific day).
POMS will be performed on Day 3, 5, 6 and 7.
|
Up to 7 days post-op
|
Readmission rates
Time Frame: 6 months
|
The amount of readmission's to hospital due to surgery related reasons.
|
6 months
|
ICU/HDU admission rates
Time Frame: 6 months
|
The amount of admissions to the Intensive Care Unit/High Dependency Unit due to surgery related reasons
|
6 months
|
ICU/HDU length of stay
Time Frame: 6 months
|
The amount of time (recorded in days) a patient spends in ICU/HDU due to surgery
|
6 months
|
Clavien-Dindo Classification Sore
Time Frame: 6 months
|
The most severe complication experienced by a patient will be assessed and recorded using the Clavien-Dindo Classification Score
|
6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Neoplasms by Site
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Neoplasms
- Lung Neoplasms
- Colorectal Neoplasms
Other Study ID Numbers
- CRFSJ0086
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Neoplasms
-
UNC Lineberger Comprehensive Cancer CenterSivan Innovation Ltd.CompletedLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of LungUnited States
-
Baptist Health South FloridaWithdrawnLung Cancer | Lung TumorUnited States
-
Oliver JonasMassachusetts General HospitalCompletedLung Cancer | Lung TumorUnited States
-
C. R. BardCompleted
-
Portsmouth Hospitals NHS TrustCompletedLung Cancer | Interstitial Lung DiseaseUnited Kingdom
-
Azienda Sanitaria-Universitaria Integrata di UdineRecruitingLung Diseases | Lung Cancer | Lung Adenocarcinoma | Lung Transplant Rejection | Lung; Node | Lung TBItaly
-
Point TherapeuticsTerminatedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, PulmonaryUnited States
-
University of UtahRecruitingLung Cancer | Lung Neoplasms/DiagnosisUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Carcinoma | Lung Neoplasm | Malignant Lung NeoplasmUnited States
-
Keimyung University Dongsan Medical CenterCompletedLung Cancer | Lung Diseases, Interstitial
Clinical Trials on High Intensity Interval Training Exercise programme
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Yasemin ASLAN KELEŞIstanbul University - Cerrahpasa (IUC)CompletedEnd Stage Renal Disease | Exercise, CompulsiveTurkey
-
Arizona State UniversityMayo Clinic; University of AlbertaCompleted
-
Riphah International UniversityRecruiting
-
Universidad Santo TomasUniversidad Nacional de Colombia; Universidad del RosarioCompletedObesity | Cognitive Function | Motor ActivityColombia
-
Kaohsiung Medical University Chung-Ho Memorial...Ministry of Science and Technology, TaiwanRecruiting
-
University of NebraskaNational Institute of General Medical Sciences (NIGMS)Terminated
-
Hasselt UniversityJessa HospitalCompletedType2 Diabetes | Diabetic CardiomyopathiesBelgium
-
University of AthensUnknown